Shaun Brothers - Jupiter Neurosciences, Consulting CoFounder
JUNS Stock | USD 9.73 1.13 10.41% |
Founder
Shaun Brothers is Consulting CoFounder of Jupiter Neurosciences, Common
Age | 46 |
Address | 1001 North US Highway 1, Jupiter, FL, United States, 33477 |
Phone | 561 406 6154 |
Web | https://jupiterneurosciences.com |
Similar Executives
Found 2 records | FOUNDER Age | ||
BEng DPhil | Telix Pharmaceuticals Limited | 48 | |
William MD | Dogwood Therapeutics, | 63 |
Jupiter Neurosciences, Leadership Team
Elected by the shareholders, the Jupiter Neurosciences,'s board of directors comprises two types of representatives: Jupiter Neurosciences, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Jupiter. The board's role is to monitor Jupiter Neurosciences,'s management team and ensure that shareholders' interests are well served. Jupiter Neurosciences,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Jupiter Neurosciences,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
Christer Rosen, CEO CoFounder | ||
Marshall Hayward, Chief CoFounder | ||
Saleem CPA, CFO Secretary | ||
Claes MD, CoChairman CoFounder | ||
Shaun Brothers, Consulting CoFounder | ||
Alexander Rosen, CoFounder Officer | ||
MS MA, Chief President |
Jupiter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Jupiter Neurosciences, a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 202.55 M | ||||
EBITDA | (4.56 M) | ||||
Net Income | (4.78 M) | ||||
Total Debt | 2.25 M | ||||
Cash Flow From Operations | (480.95 K) | ||||
Market Capitalization | 200.22 M | ||||
Total Asset | 148.59 K | ||||
Retained Earnings | (23.58 M) | ||||
Net Asset | 148.59 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Jupiter Stock Analysis
When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.